Silo Pharma, Inc. (SILO)
NASDAQ: SILO · IEX Real-Time Price · USD
1.710
-0.040 (-2.29%)
May 8, 2024, 9:52 AM EDT - Market open

Silo Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Silo Pharma stock has a target of 10, which predicts an increase of 484.80% from the current stock price of 1.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $10 $10 $10
Change +484.80% +484.80% +484.80% +484.80%
* Price targets were last updated on Aug 28, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for Silo Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24
Strong Buy 11
Buy 00
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Laidlaw & Co.
Laidlaw & Co.
Strong Buy
Initiates
$10
Strong Buy Initiates $10 +484.80% Aug 28, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
73.44K
from 72.10K
Increased by 1.86%
Revenue Next Year
73.44K
from 73.44K
EPS This Year
-0.57
from -1.20
EPS Next Year
-0.71
from -0.57
Year 2019202020212022202320242025202620272028
Revenue
40.57K-71.26K72.10K72.10K73.44K73.44K73.44K73.44K73.44K
Revenue Growth
---1.18%-1.86%----
EPS
-2.00-3.001.30-1.71-1.20-0.57-0.71-0.73-1.14-1.23
EPS Growth
----------
No. Analysts -----33333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 75,600 75,600 75,600 75,600 75,600
Avg 73,440 73,440 73,440 73,440 73,440
Low 70,560 70,560 70,560 70,560 70,560

Revenue Growth

Revenue Growth 20242025202620272028
High
4.9%
2.9%
2.9%
2.9%
2.9%
Avg
1.9%
- - - -
Low
-2.1%
-3.9%
-3.9%
-3.9%
-3.9%

EPS Forecast

EPS 20242025202620272028
High -0.59 -0.74 -0.76 -1.18 -1.27
Avg -0.57 -0.71 -0.73 -1.14 -1.23
Low -0.55 -0.69 -0.71 -1.10 -1.19

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.